Health & Fitness
Health and Fitness
Health and Fitness
Tue, May 31, 2011
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
[ Tue, May 31st 2011
] - Market Wire
Mon, May 30, 2011
[ Mon, May 30th 2011
] - Market Wire
Fri, May 27, 2011
[ Fri, May 27th 2011
] - Market Wire
[ Fri, May 27th 2011
] - Market Wire
[ Fri, May 27th 2011
] - Market Wire
[ Fri, May 27th 2011
] - Market Wire
[ Fri, May 27th 2011
] - Market Wire
[ Fri, May 27th 2011
] - Market Wire
Thu, May 26, 2011
[ Thu, May 26th 2011
] - Market Wire
Northwest Biotherapeutics ampla ms su ensayo actual sobre el cncer cerebral
BETHESDA, Md.--([ BUSINESS WIRE ])--Northwest Biotherapeutics (OTCBB:NWBO) ha anunciado que ha acelerado la incorporacin de los sitios para los ensayos clnicos, superando sus previsiones para duplicar dichos sitios en Estados Unidos este trimestre, para la inscripcin de nuevos pacientes en el ensayo clnico controlado por placebo, doble ciego, aleatorio de 240 pacientes de la empresa de la inmunoterapia DCVax® para glioblastoma multiforme (GBM), la forma ms letal de cncer cerebral.
El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.
Contributing Sources
